Rajkamal Synthetics Limited disclosed the outcome of its Board of Directors meeting held on Thursday, August 13, 2026, which commenced at 4:00 PM and concluded at 7:00 PM. The board considered and approved the unaudited financial results (standalone and consolidated) for the quarter ended June 30, 2026, along with the limited review report, pursuant to Regulation 33 of the SEBI (LODR) Regulations, 2015.

Standalone Financial Results (Quarter ended June 30, 2026)

The company reported a standalone net loss of ₹13.53 lakh for Q1 FY27, compared to a net profit of ₹6.18 lakh in the same quarter last year (Q1 FY26). Key financial figures include:

  • Total Income: ₹0.00 lakh (compared to ₹143.36 lakh in Q1 FY26 and ₹119.71 lakh in Q4 FY26)
  • Total Expenses: ₹13.61 lakh
  • Profit/(Loss) before Tax: (₹13.61) lakh (compared to profit of ₹8.51 lakh in Q1 FY26)
  • Tax Expenses: Deferred tax credit of ₹(0.08) lakh
  • Other Comprehensive Income: (₹0.01) lakh
  • Total Comprehensive Income: (₹13.55) lakh
  • Paid-up Equity Share Capital: ₹660.20 lakh (unchanged)
  • Earnings Per Share (Basic & Diluted): (₹0.20) (compared to ₹0.09 in Q1 FY26)

Consolidated Financial Results (Quarter ended June 30, 2026)

The consolidated results, which include three subsidiaries, showed a net loss of ₹8.52 lakh for Q1 FY27, compared to a net profit of ₹8.24 lakh in Q1 FY26. Key figures include:

  • Revenue from Operations: ₹105.63 lakh (compared to ₹143.36 lakh in Q1 FY26)
  • Other Income: ₹0.00 lakh (compared to ₹3.88 lakh in Q1 FY26)
  • Total Income: ₹105.63 lakh (compared to ₹147.25 lakh in Q1 FY26)
  • Purchase of Stock in Trade: ₹219.64 lakh
  • Changes in Inventories: (₹132.29) lakh
  • Total Expenses: ₹114.22 lakh
  • Profit/(Loss) before Tax: (₹8.59) lakh (compared to profit of ₹10.56 lakh in Q1 FY26)
  • Tax Expenses: Deferred tax credit of ₹(0.08) lakh
  • Other Comprehensive Income: (₹0.01) lakh
  • Total Comprehensive Income: (₹8.53) lakh
  • Paid-up Equity Share Capital: ₹660.20 lakh (unchanged)
  • Earnings Per Share (Basic & Diluted): (₹0.13) (compared to ₹0.12 in Q1 FY26)

Subsidiaries Included in Consolidation

The consolidated results incorporate the financials of three subsidiary companies:

1. Eliraluxe Skincare Private Limited (Wholly-Owned Subsidiary)

2. RKR Mines and Minerals Private Limited (Wholly-Owned Subsidiary)

3. Indoframe Industries Private Limited (Partially Owned Subsidiary)

These subsidiaries contributed total revenue of ₹105.63 lakh and a net loss of ₹(8.52) lakh for the quarter.

Regulatory Compliance and Review

The financial results were:

  • Reviewed by the company's audit committee
  • Approved by the board of directors on August 13, 2026
  • Subject to limited review by the statutory auditors, ADV & Associates (FRN: 128045W)
  • Prepared in accordance with Indian Accounting Standards (Ind AS) prescribed under Section 133 of the Companies Act, 2013
  • Filed pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015

The auditors issued a review report stating that nothing came to their attention causing them to believe the statements contain material misstatements or fail to disclose required information. They noted that balances of trade receivables, trade payables, and advances are subject to confirmations and subsequent reconciliation.

Additional Information

  • The company operates in a single business segment (textiles)
  • Previous period figures have been regrouped/recasted where necessary
  • The full financial results are available on BSE website (www.bseindia.com) and company website (www.rajkamalsynthetics.com)
  • The information will be published in newspapers as required under Regulation 47 read with Regulation 33 of SEBI (LODR) Regulations